FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1031-1033 April 13, 1995 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Stern, R. S. Related Article by Kessler, D. A.

To the Editor: The article by Kessler et al. (Nov. 17 issue)¹ provides a useful summary of questionable promotional activities by pharmaceutical companies. It does not discuss, however, the inappropriate promotional use of published and unpublished clinical studies. Dr. Kessler gave examples of the questionable use of data in a letter in 1992.² As the statistician who reviewed the studies cited in promotional material from October 1991 to October 1993, including the critique of the antiulcer medication claimed to benefit smokers,¹ I found that the majority of promotional claims referred to me citing clinical studies violated the advertising regulations of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Katz, K. A. (2008). Time to Nip "Seeding Trials" in the Bud. Arch Dermatol 144: 403-404 [Full Text]